INTRODUCTION AND OBJECTIVES: Patient selection for confirmatory tests of primary aldosteronism (PA) is one of the challenges in clinical practice because of fluctuations in serum aldosterone and renin concentrations. The aim of the present study was to validate the PA discrimination score that we created for the selection criteria of confirmatory tests.
METHODS: An aldosteroneerenin ratio cutoff !200, with plasma aldosterone concentration (PAC) !120 pg/mL was used for PA screening. We developed a discrimination formula (-1*(PAC*-0.0067 þ plasma renin activity*0.0546 þ presence of hypertension (HTN) *-1.0433 þ serum potassium levels (K)*1.6904-5.3494)) for the selection criteria of confirmatory tests. For this discrimination formula, we included 123 patients with PA who underwent unilateral adrenalectomy in our hospital between 2000 and 2017 as positive patients with PA. As negative controls, we selected 2143 PA screening-negative subjects in comprehensive medical examinations of PA for 2276 individuals of the community-dwelling population who presented to the Iwaki Health Promotion project between May 2014 and May 2015. For this validation study, we analyzed two groups: PA-positive and -negative cases. PA-positive patients comprised 10 patients with PA who underwent unilateral adrenalectomy in our hospital in 2018. PAnegative patients comprised 19 patients who underwent confirmatory tests for PA in our hospital, but did not fulfill the diagnosis of PA. Predictive accuracy of the PA discrimination score was evaluated based on ROC analysis and area under the curve (AUC). In addition, we analyzed the discrimination scores from medical examinations of PA in 1148 individuals of the community-dwelling population in 2016.
RESULTS: The discrimination formula showed a significant association with PA diagnosis (AUC: 0.97). Of the 1148 subjects, 314 (27%) were HTN patients. Thirty-one (9.9%) were positive for PA screening, representing an overall prevalence of 2.7%. We could detect 7 subjects with the cutoff value of 1.5 that were strongly suspicious for PA.
CONCLUSIONS: The PA discrimination score may improve the diagnostic accuracy of PA in screening settings. Further validation studies are warranted. 
MP69-03 IMPACT OF LAPAROSCOPIC ADRENALECTOMY ON CARDIAC FUNCTION IN PATIENTS WITH PRIMARY ALDOSTERONISM
Yoshihide Kawasaki*, Shigeto Ishidoya, Yasuhiro Kaiho, Shuichi Shimada, Tomonori Sato, Shinichi Yamashita, Koji Mitsuzuka, Akihiro Ito, Sendai, Japan INTRODUCTION AND OBJECTIVES: A major target of aldosterone is the distal tubule of the kidney, acting through mineralocorticoid receptors (MRs) on the epithelial cells of the renal tubules. MRs have recently been reported to exist in vascular endothelium and cardiac muscle, meaning that aldosterone would also act directly on those organs and potentially provoke cardiovascular pathologies. This study therefore evaluated the incidence of cardiac hypofunction and low ejection fraction (EF) among patients with primary aldosteronism (PA), and the influence of laparoscopic adrenalectomy (LADX) on improvement of EF in patients with PA. METHODS: We retrospectively investigated patients who underwent LADX for unilateral PA in our hospital between August 2008 and July 2017. Background characteristics, perioperative blood biochemical data and echocardiographic data were evaluated to elucidate incidence of low EF (< 60%) and factors contributing to low EF among PA patients. EF was determined by echocardiogram as: EF [ stroke volume (left ventricular end-diastolic dimension -left ventricular end-systolic dimension) a$ left ventricular end-diastolic dimension. RESULTS: Among the 241 patients who underwent LADX for unilateral PA during the study period, we identified 24 (10%) with low EF. Median age was 53 years, and 19 were male (79%). Median EF improved significantly from 54% (range, 20.8-59%) to 67% (range, 50-71%) after LADX (P<0.0012). As a reason for this improvement, increased left ventricular end-diastolic dimension was demonstrated on echocardiography in all of 24 patients after LADX (Table) . Univariate analysis indicated that male sex and excessive serum aldosterone were important factors contributing to preoperative low EF in PA patients. Normalization of serum aldosterone appeared to improve cardiac function in PA patients, because all patients with low EF had been taking anti-MR agents such as spironolactone and/or eplerenone preoperatively.
CONCLUSIONS: Our results suggested that excessive serum aldosterone could contribute to low EF, especially among male patients
